SAT1
MOLECULAR TARGETspermidine/spermine N1-acetyltransferase 1
SAT1 (spermidine/spermine N1-acetyltransferase 1) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SAT1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Diminazene | 0.69 | 1 |
| 2 | pentamidine | 0.69 | 1 |
| 3 | Spermine | 0.69 | 1 |
About SAT1 as a Drug Target
SAT1 (spermidine/spermine N1-acetyltransferase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented SAT1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SAT1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.